Objective: To evaluate the therapeutic efficacy and safety of immunosuppressive therapy (IST) combined with recombinant human thrombopoietin (rhTPO) for severe aplastic anemia (SAA) in pediatric patients. Method: A retrospective case-control study was conducted and the clinical data of 45 pediatric...
Bibliographische Detailangaben
| Veröffentlicht in: | Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 55(2017), 7 vom: 02. Juli, Seite 523-528
|
|---|
| 1. Verfasser: |
Zhou, K
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Liu, C X,
Li, Y,
Li, J P,
Fan, H H,
Zhang, L,
Jing, L P,
Peng, G X,
Ye, L,
Song, L,
Zhao, X,
Yang, W R,
Wu, Z J,
Chen, F,
Zhang, F K |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Chinese |
|---|
| Veröffentlicht: |
2017
|
|---|
| Zugriff auf das übergeordnete Werk: | Zhonghua er ke za zhi = Chinese journal of pediatrics
|
|---|
| Schlagworte: | Journal Article
Anemia, aplastic
Child
Immunosuppression
Thrombopoiesis
Immunosuppressive Agents
Recombinant Proteins
Thrombopoietin
9014-42-0 |
|---|